Abstract Conditional gene inactivation using the Cre/loxP system has lead to significant advances in our understanding of the function of genes in a wide range of disciplines. It is becoming increasingly apparent in the literature, that Cre transgenic mice may themselves have a phenotype. In the following study we describe the bone phenotype of a commonly used Cre transgenic mouse line to study osteoblasts, the Osx-GFP::Cre (Osx-Cre) mice. Cortical and trabecular bone parameters were determined in the femurs of Osx-Cre mice at 6 and 12 weeks of age by microtomography (lCT). At 6 weeks of age, Osx-Cre mice had reduced body weight by 22% (P \ 0.0001) and delayed cortical bone expansion and accrual, characterized by decreases in periosteal circumference by 7% (P \ 0.05) and cortical thickness by 11% (P \ 0.01), compared to wild type controls. Importantly, the cortical bone phenotype of the skeletally immature Osx-Cre mice at 6 weeks of age could be accounted for by their low body weight. The delayed weight gain and cortical growth of Osx-Cre mice was overcome by 12 weeks of age, with no differences observed between Osx-Cre and wild type controls. In conclusion, Osx-Cre expressing mice display a delayed growth phenotype in the absence of doxycycline treatment, evidenced by decreased cortical bone expansion and accrual at 6 weeks of age, as an indirect result of decreased body weight. While this delay in growth is overcome by adulthood at 12 weeks of age, caution together with appropriate data analysis must be considered when assessing the experimental data from skeletally immature Cre/loxP knockout mice generated using the Osx-Cre mouse line to avoid misinterpretation.
Introduction
The Cre/loxP system, which enables the deletion of a gene of interest in a tissue-and/or time-specific manner, has lead to significant advances in our understanding of the function of target genes in a wide range of disciplines. The application of the Cre/ loxP system is particularly advantageous in tissues that are heterogeneous in nature, such as bone. Our initial aim was to apply Cre/loxP technology in order to study the hormonal control of osteoblasts, the cells responsible for bone formation. Osteoblast development includes passage through three separate stages; (1) proliferation, (2) matrix development and maturation stage when collagen and other structural proteins are synthesized which is mineralized during the (3) mineralization stage (Owen et al. 1990 ). Our specific aim was to investigate the role of specific hormone receptors expressed by osteoblasts known to be important in bone development, growth and maintenance, using the Cre/loxP system. For this purpose we employed the Osx-GFP::Cre (Osx-Cre) mouse line which contains a tTA and a tetracycline responsive element-controlled GFP/Cre fusion protein under the control of the osterix (Sp7) promoter (Rodda and McMahon 2006) . In the absence of doxycycline, a tetracycline analogue, it has been shown that the expression of the EGFP-Cre fusion protein is restricted to the osteoblast lineage throughout embryonic and early postnatal development (Rodda and McMahon 2006) . Mating of the Osx-Cre mouse line with a floxed mouse line, in which the region of the target gene to be deleted is flanked by loxP sites, generates a Cre/loxP knockout mouse line, which when treated with doxycycline, prevents expression of the EGFP-Cre fusion protein and recombination of the target gene. This therefore also allows the deletion of the target gene to be controlled in a time specific manner by the withdrawal of doxycycline.
When using the Cre/loxP system, it is important to include both floxed and Cre transgenic littermate controls in all analyses to ensure accurate interpretation of the observed phenotype as the insertion of loxP sites into the target gene in the floxed mouse, and random integration in the genome or knock-in of the Cre transgene in endogenous loci, together with high levels of Cre expression have been documented to have non-specific effects (Davey and MacLean 2006; Schmidt-Supprian and Rajewsky 2007) . Accordingly, when we generated conditional knockouts of specific hormone receptors in osteoblasts by breeding floxed hormone receptor mouse lines with the Osx-Cre mice, we included both Osx-Cre and wild type littermate controls in our analyses. Of significant interest, we noted that the skeletally immature Osx-Cre mice had a cortical bone phenotype as an indirect result of the low body weight observed in these mice, which was overcome by adulthood. These findings are of particular importance given the increasing, widespread use of the Osx-Cre mouse line to generate osteoblastspecific knockouts. Whilst our data does not entirely invalidate the use of the Osx-Cre mouse line in bone research, caution however must be taken in interpreting and analyzing the data obtained from skeletally immature Cre/loxP knock out mice generated using this mouse line. Furthermore, this study reinforces that it is imperative that Cre transgenic littermate controls are included for direct side-by-side comparison with wild type and Cre/loxP knockouts.
Materials and methods

Materials
Generation of the Osx-Cre mice has been described previously (Rodda and McMahon 2006) . Briefly, the tTA regulated GFP::Cre construct was introduced into the first exon of the Osx1 gene using standard BAC recombination methods. The targeted BAC was then used to generate Osx-Cre mice by pronuclear injection. As bone mineral density is profoundly influenced by genetic background (Akhter et al. 1998; Beamer et al. 1996) , the Osx-Cre mice were transferred to a congenic C57BL/6 background for at least 4 generations prior to use in experiments. Wild type littermates were used as controls in all analyses. Mice were supplied with water and standard chow (Ridley Agriproducts) ad libitum, and were housed at 22°C in a 12-h light/dark cycle in standard cages. The OsxCre mice were not treated with doxycycline in order to allow transgene expression and therefore recombinase activity, to be present from early development when osterix is expressed, in order to investigate the role of hormone receptors in bone growth and development. All procedures involving animals were approved by the Austin Health Animal Ethics Committee.
Bone analyses
Femur length was measured using a digital calliper (Eta-lon Switzerland). The microarchitecture of the femora of 6 and 12 week old Osx-Cre mice were evaluated using a microtomographic imaging system (Skyscan 1174, Brussels, Belgium). Transverse CT slices of the femur were acquired using a 6.5 lm slice increment. Cortical parameters were determined in a 0.65 mm region of cortical bone, equivalent to 100 CT slices, centered on a CT slice located one third of the total femoral length from the distal end. Cortical thickness, periosteal circumference and medullary volume were determined using CTan software (v1.7, Skyscan, Belgium). Trabecular bone parameters were determined in the metaphyseal region of the distal femur and were a function of femur length as previously described (Chiang et al. 2009; Davey et al. 2008) . Trabecular bone parameters were delineated manually and evaluated in the volume of interest commencing from just below the growth plate extending 1.6 and 1.76 mm in mice aged 6 and 12 weeks respectively. Images were reconstructed and thresholded using a specimen-specific threshold. Trabecular morphometric parameters (volume, thickness, number and separation) were computed using a direct 3D approach using CTan software (v1.7, Skyscan, Belgium).
Quantitative real time PCR (Q-PCR)
Cre mRNA expression was determined in the long bones of Osx-Cre mice at 6 and 12 weeks of age and in the brains of Osx-Cre mice at 12 weeks of age by Q-PCR as we have described (Turner et al. 2011) . Osterix mRNA expression was determined in the long bones of wild type control and Osx-Cre mice at 6 and 12 weeks of age. We used Applied Biosystems TaqMan gene expression assays (Osterix: Mm00504574_m1, Cre: custom designed assay previously described by Chen et al. 2007 ). Relative expression was calculated using the DDC T method, normalized to mouse b-actin (Mm00607939_s1) as a measure of cell number, to control for variability in cDNA concentration and expressed relative to a reference control, with n C 8 independent samples/group.
Tissue specificity of Cre-mediated recombination in Osx-Cre mice To confirm that the level of Cre expression detected in the Osx-Cre mice was sufficient to result in recombination of a target gene in vivo, Osx-Cre mice were bred with our floxed androgen receptor mouse line (Notini et al. 2005) . mRNA was extracted from bone, brain and heart of Osx-ARKO mice at 6 weeks of age, cDNA synthesized and target gene deletion determined by PCR as previously described (Notini et al. 2005) .
Statistical analyses
To ensure bone analyses were of sufficient power to detect significant differences, power calculations were performed. These calculations were based on the most variable bone histomorphometric parameter for both cortical (periosteal circumference) and trabecular (trabecular bone volume) bone for mice at 6 weeks of age, when bone turnover rates are high and more variable than those observed in adult mice. A sample size of 7 mice/group is required to detect a difference of 0.75 mm in periosteal circumference (SD = 0.5) and a sample size of 5 mice/group is required to detect a difference of 5% in trabecular bone volume (SD = 2.8) between the groups at a significance level of 0.05 and a power of 80%. All experimental groups were of equal or greater sample size than indicated by these power calculations.
To compare means of two groups, unpaired Student's t test was used, with Levene's test for homogeneity of variance. As changes in body weight can indirectly affect bone structure through mechanical loading, analysis of covariance (ANCOVA) was used to determine the influence of genotype on cortical and trabecular bone parameters after controlling for body weight. All data were analysed with SPSS for MacOSX. A value of P \ 0.05 was considered significant.
Results and discussion
Whilst it has been previously documented that the skeletons of Osx-Cre embryos do no differ significantly from wild type littermate controls (Rodda and McMahon 2006) , we observed that the previously reported delay in growth in Osx-Cre mice (Berman et al. 2008; Walkley et al. 2008) , was associated with delayed cortical bone expansion and accrual, and reduced body weight. The cortices of the long bones of Osx-Cre mice were smaller and thinner, characterized by decreased perisosteal circumference and cortical thickness by 7 (P \ 0.05) and 11% (P \ 0.01) respectively, compared to wild type littermates at 6 weeks of age (Fig. 1a-c) , while medullary volume was unaffected (Fig. 1d) . The decreased cortical bone expansion and accrual observed in the Osx-Cre mice was overcome by 12 weeks of age, such that cortical bone parameters in the Osx-Cre mice did not differ from wild type controls (Fig. 1b-d) . The body weight of the Osx-Cre mice at 6 weeks of age was decreased by 22% compared to wild type (P \ 0.0001) (Fig. 3a) , and while the mean value for femur length was 5% shorter in Osx-Cre mice than in wild type mice, this did not reach statistical significance at the 0.05 level (P = 0.07; Fig. 3b ). The reduced body weight in the Osx-Cre mice was also overcome by maturity at 12 weeks of age (Fig. 3a) , which is consistent with previous reports documenting that the growth delay in Osx-Cre mice resolved with age, with Osx-Cre mice being a similar size to controls by 2-3 months of age (Berman et al. 2008) . The delayed cortical bone expansion and accrual observed in the skeletally immature Osx-Cre mice at 6 weeks of age was not associated with any changes in trabecular bone parameters (trabecular bone volume, number, thickness and separation; Fig. 2a-d) .
To our knowledge, this is the first report of a cortical bone phenotype in the skeletally immature Osx-Cre mouse. Previous studies utilizing the Osx-Cre mouse line to generate osteoblast-specific knockouts have not included littermate Osx-Cre transgenic controls in the analysis of cortical and trabecular bone by micro CT and bone histomorphometry (Berman et al. 2008; Chang et al. 2008; Greenblatt et al. 2010; Walkley et al. 2008; Zhu et al. 2011) . The importance of including Osx-Cre transgenic controls in these studies was perhaps overlooked given that the Osx-Cre appeared to overcome any delays in weight gain and growth by 2 months of age (Berman et al. 2008) . However, it is interesting to note that Razidlo et al. did report as supplementary data, minor craniofacial defects in the skulls of 5.5 week old Osx-Cre, characterized by an extended snout (Razidlo et al. 2010) .
It is well established that bone mass is highly correlated with body weight, and that mechanical loading is essential during growth for the formation of strong, weight-bearing bones (Bergmann et al. 2010; Turner et al. 2009 ). It is highly likely therefore, that the decrease in cortical bone expansion and accrual in the skeletally immature Osx-Cre mice at 6 weeks of age can be attributed to the low body weight observed in these mice. In support of this hypothesis, once corrected for changes in body weight using analysis of covariance, there were no significant differences in periosteal circumference or cortical thickness between the Osx-Cre and wild type control mice at 6 weeks of age. Whilst it is not common practice in the literature to present histomorphometric bone parameters per gram of body weight in mice, we have presented the cortical and trabecular bone parameters of the Osx-Cre mice in this manner in Fig. 4a-g Values are mean ± SE, n C 11 for 6 week group and n = 7 for 12 week group. *P \ 0.05; **P \ 0.01 versus wild type at the same age, unpaired Student's t test expansion and accrual in the skeletally immature OsxCre mice, whilst trabecular bone appears to be unaffected, may possibly be attributed to the rapid expansion of the cortical compartment that occurs during growth. It is interesting to note that following correction for body weight, that the trabecular parameters, trabecular number (P \ 0.005) and trabecular separation (P \ 0.05) were significantly increased in the Osx-Cre mice compared to wild type controls at 6 weeks of age (Fig. 4e, g ). Whilst these changes in trabecular structure are modest and do not significantly effect trabecular bone volume, these data do suggest however, that in addition to the profound indirect effect of low body weight on cortical bone in Osx-Cre mice, the expression of the tTA regulated GFP::Cre transgene in osteoblasts may also be affecting osteoblast function. The effects of alterations in osteoblast function may be more likely to be detected in trabecular bone than cortical bone due to its higher surface area and increased metabolic activity. The marked reduction in body weight of Osx-Cre mice at 6 weeks of age may be due to non-osseous expression of the tTA regulated GFP::Cre transgene. Whilst it is widely accepted that osterix is expressed specifically by osteoblasts, a recent study by Park et al. identified significant levels of osterix expression in the brain of mice (Park et al. 2011) . Consistent with this finding, we found Cre to be expressed in the brains of Osx-Cre mice at similar levels to those expressed in bone at 6 weeks of age (Fig. 5b) . Furthermore, by mating a floxed mouse line with the Osx-Cre mice, we showed that the level of Cre expression in the bones and brain of Osx-Cre mice was sufficient to result in recombination of a floxed target gene in vivo (Fig. 5c ). The expression of the tTA regulated Cre::GFP transgene in the brain of Osx-Cre mice may therefore result in Cre toxicity or indirect gene alterations within the brain, such as recombination between cryptic or pseudo loxP sites (Schmidt-Supprian and Rajewsky 2007), which in turn may effect the central regulation of body weight resulting in the indirect effects observed on cortical bone. Whilst the lower body weight in the Osx-Cre mice can account for their smaller bones at 6 weeks of age, Values are mean ± SE, for cortical parameters (a-c): n C 10 for 6 week group and n = 6 for 12 week group; for trabecular parameters (d-g): n C 11 for 6 week group and n = 6 for 12 week group. *P \ 0.05; **P \ 0.01 versus wild type at the same age, ANCOVA this does not rule out the possibility that expression of the tTA regulated GFP::Cre transgene in bone and brain may at least in part, be contributing directly to the bone phenotype, particularly as modest changes in the trabecular parameters number and separation were significant following correction for body weight. High levels of Cre expression in transgenic mice have been associated with genotoxic effects with observations of reduced neuronal proliferation and cell death when expressed at high levels in the central nervous system (Forni et al. 2006 ) and cardiomyopathy and heart failure when expressed at high levels in the heart (Buerger et al. 2006) . The levels of Cre expression in the bones of Osx-Cre mice are 4.4-fold higher at 6 than 12 weeks of age (Fig. 5a) , consistent with the decreased cortical bone growth phenotype, which resolved with age. The higher level of Cre expression in the bones of Osx-Cre mice at 6 weeks of age is not surprising given that the expression of osterix is also elevated in this age group, decreasing to a lower level of expression by 12 weeks of age (P = 0.07; Fig. 5d ), consistent with the age related decline in bone turnover (Ferguson et al. 2003) . Osterix mRNA levels did not differ between control and Osx-Cre mice at either age (Fig. 5d) , suggesting that the knock-in of the tTA regulated GFP::Cre construct into exon 1 of the osterix gene did not alter its endogenous expression. Direct measures of bone formation using fluorchrome labeling however, are required to confirm that the high levels of Cre expression observed in the bones of the Osx-Cre mice at 6 weeks of age are directly affecting osteoblast function. The apparent resolution of the delayed weight gain and growth in the Osx-Cre may not be that surprising as it has been postulated that whilst it is likely many Cre-expressing mouse strains do not have a completely normal phenotype, they may Another potential mediator of the observed growth delay observed in the Osx-Cre mice is tTA expression. Consistent with many other studies using these mice (Chang et al. 2008; Greenblatt et al. 2010; KolpakovaHart et al. 2008; Razidlo et al. 2010; Rodda and McMahon 2006) , in the present study we did not treat the Osx-Cre mice with doxycycline to suppress Cre expression, as we required Cre-mediated recombination of the target gene to occur from early in development in order to investigate the hormonal control of bone formation during development and growth. Overexpression of the same VP16 transactivation domain of the herpes simplex virus fused to the tTA protein used to generate the Osx-Cre mice (Kistner et al. 1996) has been shown to result in squelching of transcriptional machinery, thereby decreasing the expression of other cellular genes and attenuation of growth rate (Kuhnel et al. 2004; Strathdee et al. 1999; Zhou et al. 2009 ).
In conclusion, Osx-Cre mice expressing Cre from early embryonic development in the absence of doxycycline treatment, have delayed growth characterized by lower body weight and smaller bones of decreased periosteal circumference and cortical thickness compared to wild type controls at 6 weeks of age, whilst trabecular bone is unaffected. This delay in cortical bone expansion and accrual, and reduced body weight in Osx-Cre mice is overcome by 12 weeks of age when the mice are skeletally mature. Importantly, the cortical phenotype of the Osx-Cre mice at 6 weeks of age can be attributed to the indirect effect of low body weight as following statistical analysis correcting for body weight, these cortical parameters are not significantly different from wild type controls. The mechanism responsible for the low body weight in the Osx-Cre mice is not known, however, may at least in part be due to indirect gene alterations occurring in the brain as a result of non-osseous Cre transgene expression. When used properly with the appropriate controls and data analysis, the Osx-Cre mice can still be used to generate significant insight into osteoblast biology in adult, skeletally mature mice. Caution however, must be taken when interpreting the bone phenotype of young, skeletally immature Cre/loxP mice generated using the Osx-Cre mice as the bone effects observed are most likely due to the lower body weight and not as a result of target gene deletion. This study further emphasizes the necessity for Cre transgenic controls to be included in all analyses, the exclusion of which, can lead to serious misinterpretation of the data.
